HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Drug Pipeline
Sys. Review
Toripalimab can induce myositis, myocarditis, and thyroiditis in patients with non-small cell lung cancer
Toripalimab Treatment Linked to Heart and Muscle Inflammation
This case report and literature review describes a 74-year-old male with stage IIIA lung squamous cell carcinoma who developed multiple immu…
A single case study shows a patient with lung cancer developed heart and muscle inflammation after receiving toripalimab treatment.
Frontiers
Oct 24, 2026
Neurology
Sys. Review
Specialist monitoring is required for managing alemtuzumab-induced thyroid dysfunction during pregnancy
Managing thyroid issues in pregnant women after alemtuzumab treatment
This case series and literature review examines the management of alemtuzumab-induced Graves' disease and TRAb-positive hypothyroidism in pr…
Pregnant women who develop thyroid issues after alemtuzumab treatment require close monitoring to manage their health and the health of thei…
Frontiers
Sep 30, 2026
Rheumatology
Sys. Review
Adrenalectomy for Cushing Syndrome May Resolve Levothyroxine-Dependent Hypothyroidism in Pregnancy
Pregnancy and Cushing syndrome may hide a thyroid issue
This case report describes a 29-year-old woman at 17 weeks of gestation with Cushing syndrome and hypothyroidism who underwent retroperitone…
A pregnant woman with Cushing syndrome was able to stop taking thyroid medication after surgery to treat her hormone levels.
Frontiers
Sep 24, 2026
Diabetes & Endocrinology
Meta-analysis
Ultrasound-guided thermal ablation achieves 67.0% euthyroidism rate at 12 months in patients with Graves' disease
Ultrasound guided heat treatment helps some patients with Graves' disease
This meta-analysis of 82 patients with Graves' disease unresponsive to antithyroid drugs found a 67.0% euthyroidism rate one year after ultr…
A new heat treatment using ultrasound guidance can help people with Graves' disease who do not respond to standard medications.
Aug 9, 2026
Diabetes & Endocrinology
FDA Approval
FDA Approves Levothyroxine Sodium Tablets for Hypothyroidism and TSH Suppression
FDA approves new thyroid hormone drug for hypothyroidism and thyroid cancer.
The FDA approved levothyroxine sodium tablets for replacement therapy in primary, secondary, and tertiary hypothyroidism, and as an adjunct …
The FDA has approved levothyroxine sodium tablets to treat hypothyroidism and as part of therapy for certain thyroid cancers. This synthetic…
FDA
May 6, 2026
Cardiology
RCT
Nurse-led care coordination fails to improve medication adherence in high-need patients
Nurse-led care coordination did not improve medication adherence for most common chronic conditions
This pragmatic randomized controlled trial tested nurse-led care coordination versus usual care in high-need, high-cost commercially insured…
A large trial found that nurse-led care coordination did not improve how often people took their diabetes, heart, or thyroid medications com…
May 1, 2026
Diabetes & Endocrinology
Meta-analysis
Meta-analysis shows associations between hypothyroidism and increased chronic kidney disease prevalence
Hypothyroidism Linked To Kidney Issues But Treatment Does Not Fix Them
This meta-analysis of 46 studies examines the relationship between hypothyroidism, including subclinical cases, and kidney outcomes.
Untreated low thyroid levels are strongly tied to worse kidney function in adults, but taking thyroid medicine does not seem to improve kidn…
Frontiers
May 1, 2026